Levine Leichtman Capital Partners, a global private equity firm, announced today that it has invested in Prime Global Medical Communications Ltd. in partnership with its founder and management team. Prime Global is a global medical communications and market access group that provides biotech, pharmaceutical and healthcare businesses with full-service professional communications, including healthcare strategy and consultancy, scientific and medical communications, consumer health, patient-integrated science, and market access.
Graeme Peterson, founder and CEO of Prime Global, commented, “Prime Global is committed to helping our clients transform global health and patient outcomes, now and for future generations. We were looking for a partner to share this vision and match our people-first culture, and we have found that in LLCP. Their expertise and investment will allow us to develop additional capabilities, platforms, and tools to deliver more value for our people, clients, and ultimately, patients.”
John O’Neill, Head of Europe at LLCP, said, “We are thrilled to partner with Prime Global and look forward to supporting its continued success. With Prime Global’s strong leadership, ambitious strategic growth plans, and great market position, we are very excited about what the future holds.”
LLCP was advised by Results Healthcare (M&A), PWC (financial & tax), Goodwin Procter (legal) and CIL (commercial).